Thompson Davis & Co., Inc. Global Blood Therapeutics, Inc. Transaction History

Thompson Davis & Co., Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$24.9 - $40.26 $3,112 - $5,032	-125 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$38.0 - $51.1 $15,200 - $20,440	-400 Reduced 76.19%	125 $5,000
Q2 2018 Aug 03, 2018	BUY	$38.7 - $50.15 $5,805 - $7,522	150 Added 40.0%	525 $24,000
Q4 2017 Feb 05, 2018	BUY	$29.7 - $45.7 $11,137 - $17,137	375	375 $15,000

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of Thompson Davis & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on Thompson Davis & Co., Inc. with notifications on news.